World Stem Cell Summit
  • About WSCS
    • About Us
    • 2026 Regenerative Medicine Essentials Course
    • Past WSCS Speakers
      • WSCS Public Day (2023)
      • Effective Patient Advocacy
      • Symposium Intersection of RegMed & Healthspan
      • Regenerative Medicine & the Commercial Space Economy
      • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page

California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients

by admin | Jan 18, 2018 | News and Opinions

Posted: January 18, 2018 January 18, 2018 – Oakland, CA   Over 650,000 Americans suffer from end-stage kidney disease – a life-threatening condition caused by the loss of kidney function. The best available treatment for these patients is a kidney...

Recent Posts

  • A quick squeeze helps CRISPR turn skin cells into neurons more efficiently
  • Scientists discover how pancreatic cancer rewrites its DNA to escape treatment
  • Meet a mouse whose brain cortex is made up of human cells
  • Rejuvenation breakthrough: Scientists reverse 60 years of aging in human cells
  • Scientists discover a hidden switch that burns fat and blocks new fat cells
  • CAR-T Cell Therapy Moves Beyond Cancer to Autoimmune Diseases
World Stem Cell Summit Logo - White version

Copyright © 2026 Regenerative Medicine Foundation, All rights reserved.

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow